Previous Close
$0.3115
Day Range
$0.3 - $0.315
Previous Day Range
$0.2958 - $0.322
Market Cap
$13.0 million USD
Day Vol.
228741
Previous Day Vol.
397084
Currency
USD
Primary Exchange
Nasdaq
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view